The first co-packaged mifepristone and misoprostol indicated for the medical termination of a developing intra-uterine pregnancy with a gestational age of up to 63 days of amenorrhea.

The Combi-Pack is marketed in Australia as MS 2-Step, in Canada as Mifegymiso, and in Japan as Mefeego.

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of Linepharma International. Not all products or indications are licensed in every country and may be subject to further local variations. For additional information, please refer to the summary of product characteristics. For advice on medical issues please consult your local medical practitioner.

Misoprostol is a prostaglandin analogue that triggers uterine contractions and relaxation of the cervix.

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of Linepharma International. Not all products or indications are licensed in every country and may be subject to local variations. For additional information please refer to the summary of product characteristics. For advice on medical issues please consult your local medical practitioner.